Boundless Bio 10% owner Kevin Tang reports acquisition of $4,677.60 in common shares
BOLD•Kevin Tang and Tang Capital Management purchased 1,949 Boundless Bio common shares at a reported $2.40 per share, increasing their reported indirect beneficial ownership to 3,035,567 shares.
1. Share purchases
Kevin Tang, a 10% owner, and Tang Capital Management purchased 1,949 Boundless Bio common shares at a reported $2.40 per share, bringing their reported indirect beneficial ownership to 3,035,567 common shares.
